Skip to Content

Renato Lenzi, MD

Present Title & Affiliation

Primary Appointment

Clinical Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Medical Director, International Center, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd. Unit 426
Unit Number: 426
Houston, TX 77030
Room Number: FC10.3030

Education & Training

Degree-Granting Education

1977 Catholic University, Rome, Italy, MD, Cum Laude, Medicine

Selected Publications

Peer-Reviewed Original Research Articles

1. McHenry M, Parker PA, Baile WF, Lenzi R. Voice analysis during bad news discussion in oncology: reduced pitch, decreased speaking rate and nonverbal communication of empathy. Support Care Cancer 20(5):1073-8, 5/2012. e-Pub 5/2011. PMID: 21573770.
2. Varadhachary GR, Spector Y, Abbruzzese JL, Rosenwald S, Wang H, Aharonov R, Carlson HR, Cohen D, Karanth S, Macinskas J, Lenzi R, Chajut A, Edmonston TB, Raber MN. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. Clin Cancer Res 17(12):4063-70, 6/2011. e-Pub 4/2011. PMID: 21531815.
3. Lenzi R, Baile WF, Costantini A, Grassi L, Parker PA. Communication training in oncology: results of intensive communication workshops for Italian oncologists. Eur J Cancer Care (Engl) 10.1111(2):2354-60, 3/2011. PMID: 20477861.
4. Costantini A, Baile WF, Lenzi R, Costantini M, Ziparo V, Marchetti P, Grassi L. Overcoming cultural barriers to giving bad news: feasibility of training to promote truth-telling to cancer patients. J Cancer Educ 24(3):180-5, 2009. PMID: 19526404.
5. Ettinger DS, Agulnik M, Cristea M, Eaton K, Fidias PM, Gockerman JP, Hameed O, Handorf C, Harris EI, Jacobs CD, Javle M, Khushalani NI, Kvols L, Lenzi R, Lewis NL, Rashid A, Saltz L, Shulman LN, Zager JS, Zhen W. Occult primary. J Natl Compr Canc Netw 6(10):1026-60, 11/2008. PMID: 19176200.
6. Varadhachary GR, Talantov D, Raber MN, Meng C, Hess KR, Jatkoe T, Lenzi R, Spigel DR, Wang Y, Greco FA, Abbruzzese JL, Hainsworth JD. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol 26(27):4442-8, 9/2008. PMID: 18802157.
7. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3496-502, 7/2008. PMID: 18640930.
8. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 102(12):2696-707, 12/2007. e-Pub 8/2007. PMCID: PMC2423805.
9. Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D. Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer 109(12):2547-56, 6/2007. PMCID: PMC2215306.
10. Lenzi R, Edwards R, June C, Seiden MV, Garcia ME, Rosenblum M, Freedman RS. Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma. J Transl Med 5:66, 2007. PMCID: PMC2248163.
11. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL. Metastatic patterns in adenocarcinoma. Cancer 106(7):1624-33, 4/2006. PMID: 16518827.
12. Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27(1):103-11, 1/2006. e-Pub 6/2005. PMCID: PMC1350610.

Abstracts

1. Varadhachary GR, Edmonston TB, Karanth S, Carlson HR, Lebanony D, Rosenwald S, Lenzi R, Spector Y, Cohen D, Raber MN. Prospective gene signature study using microRNA to predict the tissue of origin (ToO) in patients with cancer of unknown primary site (CUP). ASCO Annual Meeting Proceedings 28(15S), 2010.
2. Parker PA, Baile W, Cohen I, Abbruzzese J, Varadhachary G, Ho L, LaPushin T, Dayao P, Lenzi R. Illness uncertainty, sense of coherence, and psychosocial adjustment in patients with pancreatic cancer. Annals of Behavioral Medicine 37S:51, 2009.
3. Lenzi R, Rashid A, Ordonez N, Raber MN, Varadhachary GR, Erlander M, Abbruzzese JL. Gene profiling validation of molecular markers in patients with cancer of unknown pirmary (CUP). ASCO Annual Meeting Proceedings 25(18S):21130, 6/2007.
4. Varadhachary GR, Talanov D, Jatkoe T, Rashid A, Lenzi R, Chadha R, Baden J, Wang Y, Abbruzzese JL, Raber MN. Prospective study of a 10-gene molecular assay to predict tissue of origin in patients with carcinomas of unknown primary (CUP). ASCO Annual Meeting Proceedings 25(18S):21096, 6/2007.

Book Chapters

1. Lenzi R. Unknown Primary Carcinoma. In: Primary Care: A Collaborative Practice, 4th. Ed(s) Buttaro TM, Trybulski J, Bailey PP, Sandberg-Cook J. Mosby Inc., Affiliate of Elsevier Inc. In Press.
2. Glover KY, Varadhachary GR, Lenzi R, Raber MN, Abbruzzese JL. Carcinoma of Unknown Primary. In: Abeloff's Clinical Oncology, 4th. Ed(s) Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG. Churchill Livingstone: Philadelphia, Pennsylvania, 2057-2074, 2008.
3. Lenzi R. Unknown Primary Carcinoma. In: Primary Care: A Collaborative Practice, 3rd. Ed(s) Buttaro TM, Trybulski J, Bailey PP, Sandberg-Cook J. Mosby: St. Louis, Missouri, 1349-1352, 2008.
4. Lenzi R, Culine S. Prognostic considerations in patients with unknown primary carcinoma. In: Carcinoma of Unknown Primary Site. Ed(s) Fizazi K. Taylor and Francis Group: New York, New York, 61-75, 2006.
5. Lenzi R, Baile WF, Rodary C, Parker PA. Psychosocial aspects of cancer of unknown primary site. In: Carcinoma of Unknown Primary Site. Ed(s) Fizazi K. Taylor and Francis Group: New York, New York, 175-190, 2006.
6. Varadhachary GR, Lenzi R. Radiographic studies, endoscopy, and serum tumor markers in the diagnostic evaluation of carcinomas of unknown primary site. In: Carcinoma of Unknown Primary Site. Ed(s) Fizazi K. Taylor and Francis Group: New York, New York, 11-22, 2006.

Manuals, Teaching Aids, Other Teaching Publications

1. Lin EH, Burton A, Lenzi R, Espirito J, Anthony L, Karp D. Cancer Matrix Manual. Ed(s) Lin EH. Advanced Medical Publishing, Inc. Madison, Wisconsin, 212-221, 2006.

Last updated: 6/17/2014